Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ipratropium add-on therapy for moderate acute pediatric asthma in the emergency department
ACTRN12612000829819Phase 4Not yet recruiting
- Sponsor
- John Hunter Hospital Emergency Department
- Start
- Sep 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ipratropium bromide, salbutamol and prednisolone in asthma (2 arms), sponsored by John Hunter Hospital Emergency Department. Primary endpoint: Rate of hospitalisation. Planned start Sep 2012; status: not yet recruiting.
02
Drugs
ipratropium bromidesalbutamolprednisolone
03
Conditions
asthma
Beyond the preview
Go deeper on ACTRN12612000829819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000829819.